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IT came to our notice that a large group of Strong A mice in another institute
fed on a diet known as " P.R.M. " unexpectedly failed to develop skin tumours
in response to twice weekly applications of 0*1 ml. 0.1 per cent 3,4-benzopyrene
for over one year. Because P.R.M. diet has a high content of vitamins of the B
group, and because there are certain theoretical reasons for believing that ribo-
flavin, in particular, might influence carcinogenesis, the experiments described
below were undertaken.
Previously Boutwell, Brush and Rusch (1949) investigated the effect of
different levels of dietary vitamins of the B group on skin carcinogenesis by
3,4-benzopyrene. They reported a somewhat lower incidence of tumours in a
group given a diet low in all B vitamins, but saw no difference in groups receiving
diets rich in all, or individual, B vitamins. However, in their experiments the
highest dietary level ofriboflavin was less than 100 ,tg. per mouse per day. More-
over, their treatment with benzopyrene (0.3 per cent in benzene twice weekly,
volume of solution not stated) was probably vastly in excess of that necessary to
induce tumours, and a small inhibitory effect may have been swamped.
In the experiments reported below, the dose-levels of riboflavin were much
higher and the concentration of benzopyrene (in Experiments II and III) much
lower.
MATERIALS AND METHODS
Mice.-" 101 " strain mice ofboth sexes were used in all experiments. Animals
were vaccinated on the tail at the age of 6-8 weeks, as a precaution against ectro-
melia, and began treatment at 8-10 weeks ofage.
Chemicals.-3,4-Benzopyrene (BP) and 9,10,-dimethyl-1,2-benzanthracene
(DMBA) were obtained from L. Light and Co. and used without further puri-
fication. Croton oil was obtained from Messrs. Stafford Allen and Co., Wharf
Road, London, N.1, in 1953 and thereafter storedin the dark at room temperature.
Acetone (Analargrade)and ThiamineB.P. wereobtainedfromBritishDrugHouses.
Riboflavin B.P., Nicotinic Acid B.P. and Pyridoxine hydrochloride B.P.C. were
obtained from " Roche ".
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Rowett Institute Formula (R.I.F.) diet prepared according to the formula of
Thomson (1936) was obtained from the North-Eastern Agricultural Co-operative
Society Limited, Bannermill Place, Aberdeen.
Diet 41B prepared according to formula of Bruce and Parkes (1949) as modi-
fied by Bruce (1950) in unpelleted powdered form was obtained from Messrs.
Dixon, of Ware, Hertfordshire.
P.R.M. diet.-The P.R.M. diet used in experiments referred to in the intro-
duction, was described to us as visibly yellow. Diet of the same formula' and
specifications was obtained from the same supplier (Messrs. Dixon of Ware,
Hertfordshire). However, it was not noticeably yellow in appearance.
Yeast ofvarious brands was obtained at frequent intervals from local suppliers.
1 Formula of P.R.M. diet:
Per cent
VVheat meal (millable grain) . . . . 20
English fine wheatfeed . . . . . 20
Finely ground oats (thin husk) . . . 20
Maize meal (yellow variety) . . . . . 9*4
Barley meal (plump grains) . . . . . 5
English white fish meal (66 per cent albuminoids) . 5
Meat and bone meal (50 per cent protein) . 8 7
Dried skim milk . . . . . . 7.5
Dried unextracted diastase yeast . . . . 2-5
Vitamin premix . . . . . . 1-25
Mineral supplement . . . . . . 065
Vitamin Premix:
Per pound
Vitamin A (stabilized) . . . . . . 140,000 I.U.
Vitamin D3 (stabilized) . . . 36,000 I.U.
Vitarnin B2 (riboflavin, nicotinic acid, folic acid) . 300 mg.
Vitamin E . . . . . . . . 900 mg.
Experiment I
After randomization, 6 groups each of 10 male and 10 female mice began
treatment with the diets and vitamins shown in Table I. Four weeks later all
groups were given a single application of DMBA (225 ,ug./0.15 ml. acetone), and
after a further 3 weeks the first of a course of 15 once-weekly applications of
0-25 ml. 0*1 per cent croton oil in acetone. After 6 weeks of croton oil treatment
papillomas began to appear in all the groups. Their incidence rose steadily,
though slightly less quickly, in Group III (given R.I.F. diet plus thiamine in the
drinking water) and Group VI (given P.R.M. diet) than in in the other 4 groups.
Table I shows the incidence of papillomas one week after the end of croton oil
treatment, and 4 weeks later.
At the beginning of the experiment the average weight of mice in all groups
was 20-7 g. At the end of the experiment Groups III and VI had put on rather
more weight than the others. The same two groups had a somewhat lowerincidence
of tumours. The association of a lower tumour incidence in these groups with a
higher rate of body weight gain is the opposite of that reported by Tannenbaum
and Silverstone (1953) in experiments where the quantity but not the quality of
the diet was varied. However there were such marked differences in the numbers
of tumours borne by individual mice that the difference in average tumour
incidence did not reach statistical significance.F. J. C. ROE
It was concluded that P.R.M. diet, or thiamine in the drinking water of mice
on R.I.F. diet, may have protected mice slightly against developing papillomas
in response to treatment with DMBA and croton oil.
TABLE I.-Effect of Riboflavin, Thiamine, Pyridoxine and Nicotinic Acid on the
Induction of Skin Papillomas by a Single Application of DMBA followed by
Repeated Applications of Croton Oil
Group Diet
I
II
III R.I.F.
TV
J
VI P.R.M. .
dri
Ribof
2 ml
mou
Thian
0.20,
Pyrid
0-04
Nicot
0-20
Applications
to skin
(begun 4 weeks
after starting
In on diet
inking + vitamins in
vater drinkingwater)
-225 pg. DMBA
in 0-15 ml.
acetone once
flavine
g. per
Lse daily
nine Then after 3-
% o week interval
Loxine
;inamide 0-25 ml. 0-1%
croton oil in
acetone once
weekly for 15
weeks
Incidence ofpapillomas at
end of croton oil treatment
Average
Mice papil-
with lomas
papil- per
Survivors lomas survivor
19 17 12-5
Incidence
of papil-
lomas
per
survivor
one month
after end
of treat-
ment
10.0
Average
weight
gain
during
experi-
ment
(g.)
5.7
19 19 12-5 . 10-7 . 5-4
20 18 9-3 . 7-3 . 6-4
18 17 14-1 . 9-1 5-8
19 17 14-6 12-1 6-1
19 18 8-4 . 7-5 7-4
Experiment II
After randomization 6 groups, each of 10 males and 10 females, were treated
as indicated in Table II. Diets and vitamin treatments were begun 4 weeks before
applications to the skin.
Papillomas began to appear in Groups VII and VIII during the 11th week, in
Groups IX and X during the 13th week, and in Groups XI and XII during the
17th week.
Treatment with DMBA and BP was stopped after 20 weeks; so too were the
injections of thiamine for Group XI in which 12 of the mice had died. All other
treatments continued. At the 20th week mice ofGroup VIII had a lower average
number ofpapillomas per surviving mouse than those ofGroup VII (4.6 as against
6.5) but the proportion ofmice bearing papillomas was the same in the two groups.
Of the four BP-treated Groups, Group XII (riboflavin) had a lower incidence of
papillomas than the others. In addition Groups VIII, IX and X had 1, 2 and 4
malignant skin tumours, respectively. During the next 13 weeks many more
malignant skin tumours arose in all the groups. As soon as the diagnosis of malig-
nancy seemed definite, tumours were removed under ether anaesthesia. By follow-
ing this procedure it was possible for mice to develop several malignant tumours
in sequence. Great care was taken to distinguish new malignant tumours from
recurrent growths.
Table II gives the totals of mice which bore malignant skin tumours, and of
malignant tumours, in each group. There was no difference in incidence between
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the two DMBA-treated groups. Among the BP-treated groups the incidence was
slightly, but not significantly, lower in Groups XI and XII than in Groups IX
and X.
Apart from those of Group XI, mice in all groups thrived and gained weight
at approximately the same rate. Those in Group XI were underweight when the
injections of thiamine were stopped at the 20th week, but thereafter picked up,
their average weights approaching those in other groups by the 33rd week.
It was concluded that neither the differences in diet not the administration of
thiamine or riboflavin affected skin carcinogenesis by repeated applications of
DMBA; but that injected riboflavin may have slightly reduced the incidence of
papillomas at 20 weeks, and of malignant tumours arising before the 33rd week,
in mice treated repeatedly with BP.
Experiment III
After randomization 3 groups each of 20 male and 20 female mice began treat-
ment with the diets shown in Table III. Four weeks later all groups began twice
weekly applications to the skin of 0-2 ml. 0-025 per cent BP in acetone.
Papillomas began to appear in Groups XIII and XIV during the 11th week
of treatment, and in Group XV two weeks later. During the next few weeks
Group XV lagged behind the other two in tumour development, but from the 18th
week onwards this difference progressively disappeared. Table III shows that
by the 23rd week there was very little difference between the three groups. The
experiment was therefore abandoned at this point.
It is perhaps of passing interest that the mice of Group XV appeared healthier
and were always on the average slightly heavier than mice in the other two groups
throughout the experiment. Survival in this group was also much better. How-
ever, it is well known that intercurrent infections frequently affect one cage of
mice more than another. Also it should be noted that Group XIV was never
intermediate between the other two groups in health, weight, or survival. There-
fore the apparent beneficial effect of riboflavin in Group XV requires confirmation.
TABLE III.-Effect of Dietary Riboflavin-level on Induction of Skin Tumours by
Repeated Applications of BP
Average
weight
Applications Tumour incidence after 23 weeks gain
to skin -- A during
(begun 4 weeks Mice Mice Total Total experi-
after start of in Sur- with benign malignant ment
Group Diet special diets) group vivors tumours tumours tumours (g.)
XII . 41B 0.2 ml. 0.025% 40 . 30 21 76 6 . 8 0
XIV . 41B + 0-2% BP in acetone . 40 . 28 25 74 6 7-2
Riboflavin . twice weekly
XV . 41B + 06% for 23 weeks 38 37 32 71 6 . 8-2
Riboflavin J
DISCUSSION
One hesitates to report experiments that give negative or inconclusive results.
However, in the field of carcinogenesis there is a tendency to invoke special factors
in the diet as being responsible for unexpected results. This was the reason for
undertaking the experiments reported, and by reporting them it is hoped that
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others will be dissuaded from setting up similar experiments. The inclusion of
0 6 per cent riboflavin in the diet of mice, equivalent to more than 150 mg. per
mouse per day, in Group XV (Experiment III) is surely a fairly stringent test of
the ability of riboflavin to inhibit carcinogenesis by repeated applications of
3,4-benzopyrene to the skin.
The mystery referred to in the introduction of the failure of Strong A mice to
develop tumours in response to applications of benzopyrenle remains unsolved.
It may have had nothing to do with diet. Alternatively, it may have been due to
a factor present in one batch of P.R.M. diet but not in others. The latter ex-
planation is supported by the fact that later batches were apparently less yellow
than earlier ones. However, detailed enquiries into the possible differences be-
tween batches have consistently failed to provide a basis for planning further
critical experiments.
Tannenbaum and Silverstone (1953) with respect to the effect of vitamins in
the diet on carcinogenesis concluded:
" Analysis of the findings on the influence of varying the level of B vitamins
suggests that wide changes in dietary content, in the range above minimal needs,
have little effect on carcinogenesis. At least, this appears to be valid for the in-
duced skin tumour and the spontaneous mammary, lung and liver tumours of
the mouse. As deficiency levels are approached there may be some inhibition of
carcinogenesis, but in these instances caloric intake and body weight changes may
be the major cause of the altered response."
This conclusion is not changed by the results ofthe experiments reported here.
SUMMARY
The administration of massive doses of riboflavin to " 101 " strain mice had
no more than a slight inhibitory effect on their development of skin tumours in
response to repeated applications of 3,4-benzopyrene. Additions ofother vitamins
of the B group had no definite effect at all.
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